ArticlePakistan journal of medical sciences2025
Predictive value of thrombotic molecular markers combined with venous thromboembolism score for thrombosis in patients with gastrointestinal malignancies.
Article in Pakistan journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the predictive value of thrombotic molecular markers, including TAT, PIC, TM, and t-PAIC, combined with the VTE score for venous thrombosis in patients with gastrointestinal malignancies. Methodology: This was a retrospective study. Two hundred and fifteen patients diagnosed with gastrointestinal malignancies at the Affiliated Hospital of Hebei University between January 2024 and March 2025 were enrolled in this study. Based on whether venous thrombosis occurred during hospitalization after treatment, patients were divided into a thrombosis group( Results: The levels of TAT, PIC were significantly higher in the thrombosis group compared to the non-thrombosis group(P<0.05, respectively). ROC curve analysis showed that the area under the curve(AUC) for TAT, PIC, TM, t-PAIC, VTE score, and the integrated model were 0.774, 0.635, 0.539, 0.573, 0.577, and 0.793, respectively. The AUC of the integrated model was significantly higher than that of TAT, PIC, TM, t-PAIC, and the VTE score alone( Conclusion: The combination of thrombotic molecular markers and VTE score has significant clinical value in predicting venous thrombosis in patients with gastrointestinal malignancies. This approach facilitates the early identification of high-risk patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.